期刊文献+

建立表达增强型绿荧光蛋白的小鼠多药耐药白血病模型 被引量:2

Establishment of murine multi-drug resistant leukemia model expressing enhanced green fluorescent protein
原文传递
导出
摘要 目的建立增强型绿荧光蛋白(EGFP)基因标记的小鼠多药耐药白血病模型。方法以磷酸钙沉淀法将pLNG蛳EGFP质粒导入ΦNX蛳E包装细胞,用脂质体转染的方法获得高滴度的EGFP病毒,并转导入小鼠多药耐药白血病细胞;采用悬浮细胞培养观察该细胞的生长规律;流式细胞术分析细胞周期分布;RT蛳PCR方法检测mdr1a基因表达;体内接种观察白血病发病情况并比较其耐药性的变化。结果将pLNG蛳EGFP质粒导入ΦNX蛳E包装细胞后,收集细胞培养上清,病毒滴度为(4.5±3.4)×106CFU/mL。病毒转染后的小鼠多药耐药白血病细胞P388/VCR蛳G能稳定地表达绿色荧光。与P388/VCR细胞相比,P388/VCR蛳G细胞倍增时间、周期分析无明显差异;RT蛳PCR检测mdr1a基因的结果为:P388/S蛳G细胞阴性,P388/VCR蛳G细胞阳性。P388/VCR蛳G细胞在DBA小鼠体内也具有耐药性。所有接种P388/VCR蛳G细胞的DBA小鼠均死于腹水型白血病。结论建立了在体内稳定表达EGFP的小鼠多药耐药白血病模型,为研究多药耐药提供一种新的工具。 Objective To establish a gene marking of murine multi- drug resistant leukemia model with enhanced green fluorescent protein. Methods MSCV- eGFP plasmid was transferred into ΦNX- E paking cell by Ca3(PO4)2 precipitation using retrovirus vector. EGFP virus producer cells were generated with liposome mediated transfection. The murine P388/VCR cell line was transduced with EGFP retrovirus. The biological characteristics of P388/VCR- G were compared with P388/VCR, in respect of cell growth curve, cell growth cycle by flow cytometer(FCM), and the expression of mdr1a gene by RT- PCR. Its change of drug resistant was compared in murine. Result The EGFP virus was obtained, when pLNG- EGFP plasmid was transferred into ΦNX- E packed cell, and its titer was (4.5±3.4)×106 infectious particles/mL. The gene transferred P388/VCR cell could express bright green fluorescence steadily. There were no significant difference of cell growth curve and cell cycle analysis between P388/VCR- G and P388/VCR cell lines. The expression of mdr1a gene in P388/VCR was negative through the detection of RT- PCR, but it was positive in P388/VCR- G. All of the mice inoculated P388/VCR- G and P388/VCR cells died of leukemia with ascites. Conclusions It was established that model expressing high level green fluorescence .This model may provide an useful tool for the study of multi- drug resistant.
出处 《白血病.淋巴瘤》 CAS 2005年第2期72-75,共4页 Journal of Leukemia & Lymphoma
基金 上海市卫生局科技发展基金资助项目(034116)
关键词 绿荧光蛋白 白血病 模型 基因转移 多药耐药 Green fluorescent protein Leukemia Model Gene transfer Multi- drug resistant
  • 相关文献

参考文献10

二级参考文献20

  • 1褚建新,赵钧铭.大鼠白血病化疗后残留白血病细胞再增殖和再迁移[J].中华血液学杂志,1993,14(7):347-350. 被引量:14
  • 2Perez- Victoria J M, Di Pietro A, Barron D, et al. Multidrug resistance phenotype mediated by the P-glycoprotein-like transporter in Leishmania: a search for reversal agents[J]. Curr Drug Targets,2002,3(4):311-333.
  • 3Schneider E, Yamazaki H, Sinha B K, et al. Buthionine sulphoximine - meliated sensitization of etoposide - resistant human breast c cer MCF7cell overexpressing the multidrug resistance-associated protein involves increased drug aceumulation[J]. Br J Cance
  • 4Longhurst T J, O'Neill G M, Harvie R M, et al. The anthrseytoline resistance- associated gene,a novel gene associated with multidrug resistance in a human leukemia cells line[J]. Br J Cancer, 1996,74:1331-1335.
  • 5Itamochi H, Kigawa J, Sultana H, et al. Sensitivity to anticancer agents and resistance echanisms in clear cell carcinoma of the ovary [J]. Jpn J Cancer Res,2002,93(6):723-728.
  • 6Hamada H, Tsuruo T. Charaterization of the ATPase activity of the Mr 170 000 to 180 000 membrane glycoprotein associated with multidrug resistance in k562/ADM cells [J]. Cancer Res, 1988,48:4926 -4932.
  • 7Fu L W, Deng Z A, Pan P C, et al. Screening and discovery of novel MDR modifiers from naturally occurring bisbenzylisoquinoline alkaloids[J]. Anticancer Res,2001,21 (4A):2273- 2280.
  • 8Mi Q, Cui B, Silva G L, et al. Pervilleine A, a novel tropane alkaloid that reverses the multidrug-resistance phenotype [J]. Cancer Res,2001,61(10):4030-4037.
  • 9LeslieEM, DeeleyRG, ColeSP. Toxicological relevance of the multidrug resistance protein 1, MRP1 (ABCC1)and related transporters[J]. Toxicology,2001,167(1):3-23.
  • 10Nagata J, Kijima H, Hatanaka H, et al. Reversal of cisplatin and multidrug resistance by ribozyme-mediated glutathione suppression [J]. Biochem Biophys Res Commun,2001,286(2):406-413.

共引文献35

同被引文献39

引证文献2

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部